Subcutaneous fat is the outermost layer of fat stored directly beneath your skin. It acts as an energy reserve and provides insulation, but excessive amounts can make you feel uncomfortable or ...

With New Year’s resolutions in full swing, lots of Americans are committing to being more fit and losing weight. One stubborn area that many of us will be battling is that squishy part around our ...

- CBL-514 is the first-in-class new drug candidate for large-area fat reduction. CBL-0204 Phase 2b study, approved by the U.S. FDA and AU TGA, met all the primary and secondary efficacy endpoints in ...

A study highlights the benefits of intermittent fasting for individuals with obesity, showing it can promote weight loss and improve heart health. Data from a new study shows that both visceral and ...

Scientists at the University of Copenhagen discovered that smoking directly triggers the growth of visceral adipose tissue.

Subcutaneous Fat Necrosis of the Newborn (SCFN) is a rare form of panniculitis that typically emerges within the first few weeks of life in both term and preterm infants. The condition is clinically ...

Obesity is a known risk factor for many diseases, but new research now suggests that where on the body fat is stored is even more critical than the number on the scale. Researchers in the UK's ...

In the United States, heart disease remains the leading cause of death, accounting for more than 915,973 deaths in 2023 alone ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...